Affymetrix (Santa Clara, California) And Genisphere Launch Best-in-Class Solution for microRNA Expression Research
Published: Mar 16, 2009
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) and Genisphere Inc. today announced the launch of a new, best-in-class solution for microRNA (miRNA) research studies. Encompassing assay, array, and software, the solution offers comprehensive miRNA coverage for 71 organisms on a single array. Covered species include human, mouse, rat, canine, and monkey — all of which are critical models for pharmaceutical and academic scientists working in oncology, stem cell research, toxicology, neuroscience, infectious disease, and many other areas.